|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1996-04-16 |
Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg DR Capsules (Takeda Pharmaceuticals America Inc., USA)
Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed release Capsules (Takeda Pharmaceuticals America Inc., USA)
100 项与 Hikma Pharma Ltd. 相关的临床结果
0 项与 Hikma Pharma Ltd. 相关的专利(医药)
100 项与 Hikma Pharma Ltd. 相关的药物交易
100 项与 Hikma Pharma Ltd. 相关的转化医学